{"title":"电痉挛疗法成功治疗双相情感障碍和7毫米脑动脉瘤患者。","authors":"Mesut Toprak, S. Wilkinson, R. Ostroff","doi":"10.1097/YCT.0000000000000389","DOIUrl":null,"url":null,"abstract":"To the Editor: M s N is a 54-year-old woman whowas admitted to our inpatient unit for exacerbation of bipolar depression, type I. Six months before admission, she experienced a brief manic episode, after which her mood dropped precipitously. After medication adjustments failed to alleviate her depression, shewas admitted for expedited initiation of electroconvulsive therapy (ECT). At the time of admission, her medications included lamotrigine, lithium, and olanzapine. Her medical history was notable for hypertension, as well as a 7-mm cerebral aneurysm located in the left cavernous sinus. Her hypertension had been successfully managed with amlodipine/valsartan/hydrochlorothiazide 10/160/12.5 mg daily. The aneurysm had been discovered incidentally from magnetic resonance imaging 4 years ago that she had for a work-up of diplopia (since resolved). Given the relatively low risk of spontaneous rupture associated with an aneurysm of this size, the patient had annual follow-up with neurosurgery for expectant management without intervention. The aneurysm had remained stable in size for the following 4 years. After consultation with neurosurgery and anesthesiology, as well as informed consent including a thorough discussion of the risks and benefits of the treatment, right unilateral ECT was initiated, administered 3 times a week using a MECTA Spectrum 5000Q machine. Methohexital was used as the anesthetic agent (dose range, 80–150 mg), succinylcholine was used as the paralytic agent (dose range,","PeriodicalId":287576,"journal":{"name":"The Journal of ECT","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2017-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Successful Treatment With Electroconvulsive Therapy of a Patient With Bipolar Disorder and a 7-mm Cerebral Aneurysm.\",\"authors\":\"Mesut Toprak, S. Wilkinson, R. Ostroff\",\"doi\":\"10.1097/YCT.0000000000000389\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"To the Editor: M s N is a 54-year-old woman whowas admitted to our inpatient unit for exacerbation of bipolar depression, type I. Six months before admission, she experienced a brief manic episode, after which her mood dropped precipitously. After medication adjustments failed to alleviate her depression, shewas admitted for expedited initiation of electroconvulsive therapy (ECT). At the time of admission, her medications included lamotrigine, lithium, and olanzapine. Her medical history was notable for hypertension, as well as a 7-mm cerebral aneurysm located in the left cavernous sinus. Her hypertension had been successfully managed with amlodipine/valsartan/hydrochlorothiazide 10/160/12.5 mg daily. The aneurysm had been discovered incidentally from magnetic resonance imaging 4 years ago that she had for a work-up of diplopia (since resolved). Given the relatively low risk of spontaneous rupture associated with an aneurysm of this size, the patient had annual follow-up with neurosurgery for expectant management without intervention. The aneurysm had remained stable in size for the following 4 years. After consultation with neurosurgery and anesthesiology, as well as informed consent including a thorough discussion of the risks and benefits of the treatment, right unilateral ECT was initiated, administered 3 times a week using a MECTA Spectrum 5000Q machine. Methohexital was used as the anesthetic agent (dose range, 80–150 mg), succinylcholine was used as the paralytic agent (dose range,\",\"PeriodicalId\":287576,\"journal\":{\"name\":\"The Journal of ECT\",\"volume\":\"9 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of ECT\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/YCT.0000000000000389\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of ECT","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/YCT.0000000000000389","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
摘要
致编辑:M s N是一名54岁的女性,因双相抑郁症i型加重而入住我们的住院部。入院前6个月,她经历了短暂的躁狂发作,之后她的情绪急剧下降。在药物调整未能缓解她的抑郁后,她被允许加速启动电休克治疗(ECT)。入院时,她的药物包括拉莫三嗪、锂和奥氮平。她的病史是高血压,以及位于左侧海绵窦的7毫米脑动脉瘤。她的高血压已成功地控制在氨氯地平/缬沙坦/氢氯噻嗪10/160/12.5 mg /天。动脉瘤是4年前在复视检查中偶然发现的(现已痊愈)。鉴于这种大小的动脉瘤自发性破裂的风险相对较低,患者每年接受神经外科随访,无需干预。在接下来的4年里,动脉瘤的大小一直保持稳定。在咨询了神经外科和麻醉学,以及知情同意,包括对治疗的风险和益处进行了彻底的讨论后,开始使用MECTA Spectrum 5000Q机器进行右单侧ECT,每周3次。以甲氧己酮为麻醉剂(剂量范围80 ~ 150mg),以琥珀胆碱为麻痹剂(剂量范围:
Successful Treatment With Electroconvulsive Therapy of a Patient With Bipolar Disorder and a 7-mm Cerebral Aneurysm.
To the Editor: M s N is a 54-year-old woman whowas admitted to our inpatient unit for exacerbation of bipolar depression, type I. Six months before admission, she experienced a brief manic episode, after which her mood dropped precipitously. After medication adjustments failed to alleviate her depression, shewas admitted for expedited initiation of electroconvulsive therapy (ECT). At the time of admission, her medications included lamotrigine, lithium, and olanzapine. Her medical history was notable for hypertension, as well as a 7-mm cerebral aneurysm located in the left cavernous sinus. Her hypertension had been successfully managed with amlodipine/valsartan/hydrochlorothiazide 10/160/12.5 mg daily. The aneurysm had been discovered incidentally from magnetic resonance imaging 4 years ago that she had for a work-up of diplopia (since resolved). Given the relatively low risk of spontaneous rupture associated with an aneurysm of this size, the patient had annual follow-up with neurosurgery for expectant management without intervention. The aneurysm had remained stable in size for the following 4 years. After consultation with neurosurgery and anesthesiology, as well as informed consent including a thorough discussion of the risks and benefits of the treatment, right unilateral ECT was initiated, administered 3 times a week using a MECTA Spectrum 5000Q machine. Methohexital was used as the anesthetic agent (dose range, 80–150 mg), succinylcholine was used as the paralytic agent (dose range,